Marcelo Gomes Afonso

Mr. Marcelo Gomes Afonso

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
ACAlexandra Cîrciumaru
Alexandra Cîrciumaru
MAMarcelo Gomes Afonso
Marcelo Gomes Afonso
HWHeidi Wähämaa
Heidi Wähämaa
AKAkilan Krishnamurthy
Akilan Krishnamurthy
MHMonika Hansson
Monika Hansson
BRBence Rethi
Bence Rethi
Background: Why the adaptive immune system turns against citrullinated antigens in rheumatoid arthritis (RA) and whether anti-citrullinated protein antibodies (ACPAs) contribute to pathogenesis are questions that have triggered intense research, but still are not fully answered. Neutrophils may be crucial in this context, both as sources of citrullinated antigens and also as targets of ACPAs. To better understand how ACPAs and neutrophils contribute to RA, we studied the reactivity of a broad spectrum of RA patient-derived ACPA clones to activated or resting neutrophils, and we also compared neutrophil binding using polyclonal ACPAs from different patients. Methods: Neutrophils were activated by Ca2+ ionophore, PMA, nigericin, zymosan or IL-8, and ACPA binding was studied using flow cytometry and confocal microscopy. The roles of PAD2 and PAD4 were studied using PAD-deficient mice or the PAD4 inhibitor BMS-P5. Results: ACPAs broadly targeted NET-like structures, but did not bind to intact cells or influence NETosis. We observed high clonal diversity in ACPA binding to neutrophil-derived antigens. PAD2 was dispensable, but most ACPA clones required PAD4 for neutrophil binding. Using ACPA preparations from different patients, we observed high patient-to-patient variability in targeting neutrophil-derived antigens and similarly in another cellular effect of ACPAs, the stimulation of osteoclast differentiation. Conclusions: Neutrophils can be important sources of citrullinated antigens under conditions that lead to PAD4 activation, NETosis and the extrusion of intracellular material. A substantial clonal diversity in targeting neutrophils and a high variability among individuals in neutrophil binding and osteoclast stimulation suggest that ACPAs may influence RA-related symptoms with high patient-to-patient variability.

11 September 2026 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
MSMarlene Schülein
Marlene Schülein
MAMarcelo Gomes Afonso
Marcelo Gomes Afonso
MSMerel Sijbranda
Merel Sijbranda
DPDiego Velasquez Pulgarin
Diego Velasquez Pulgarin
ADAnatoly Dubnovitsky
Anatoly Dubnovitsky
BRBruno Raposo
Bruno Raposo
Autoreactive T cells recognising citrullinated antigens, although rare and difficult to study, are implicated in rheumatoid arthritis (RA). To allow functional studies and manipulation of such T cells, we have generated and characterised transgenic mice expressing a T-cell receptor (TCR) cloned from a patient with RA and reactive with a prominent target, citrullinated tenascin C (citTNC). A humanised TCR transgenic (hTCR-tg) mouse recognising the citrullinated tenascin C22 (citTNC22) antigen in an HLA-DRB1*04:01 (HLA-DR4) restricted manner was developed by genetically engineering a chimeric TCR expressing murine constant domains and human V(D)J sequences. hTCR-tg mice were immune phenotyped in murine H-2b and humanised HLA-DR4 backgrounds using full-spectrum flow cytometry, cytokine enzyme-linked immunosorbent assays, and Fluorospot assays at steady state and after antigen challenge. Additionally, we investigated the presence of antibodies to citTNC and arthritis after citTNC protein immunisation. Thymic selection of hTCR T cells differed between the 2 major histocompatibility complex class II alleles, with normal CD4+ T-cell development observed solely under HLA-DR4 restriction. The chimeric hTCR maintained its citTNC22 specificity in vitro and ex vivo, without cross-reactivity to native TNC22 or other citrullinated autoantigens. hTCR-tg CD4+ T cells responded to antigen challenge in vivo and provided support to IgG class-switch and antigen-specific antibody production. Moreover, protein-immunised hTCR-tg mice developed arthritis after periarticular challenge with citTNC. hTCR-tg mice expressing an RA patient-derived autoreactive TCR develop functional antigen-specific and HLA-restricted CD4+ T cells. The combination of humanised HLA-DR4 and TNC22 mice will be a valuable tool in the development of antigen-specific therapies translatable to human disease.